Surveillance for early gastric cancer after endoscopic submucosal dissection and H.pylori eradication.

Surveillance for early gastric cancer after endoscopic submucosal dissection and H.pylori eradication. - Surveillance for early gastric cancer after endoscopic submucosal dissection.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001057

Enrollment

100

Registered

2008-02-27

Start date

2008-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as early gastric cancer and are considered as the indication of endoscopic submucosal dissection.

Exclusion criteria

Exclusion criteria: Patients who have anticoagulant therapy. Patients who had total gastrectomy during the course observation. Patients who do not respond to 2nd eradication thrapy of H.pylori.

Design outcomes

Primary

Measure	Time frame
Recurrence of gastric cancer after endoscopic submucosal dissection and Aberrant DNA methylation and aberrant expression of microRNAs, DNA, and proteins, including CD44v9, CagA and stemness-related factors, in gastric tumors and in background gastric mucosa such as atrophic and metaplastic mucosa	—

Countries

Japan

Contacts

Public ContactHidekazu Suzuki

Keio University, School of Medicine Division of Gastroenterology and Hepatology

hsuzuki@a6.keio.jp03-5363-3914

Outcome results